• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年痴呆患者的药物依从性:一项系统文献综述

Medication Adherence in Older Patients With Dementia: A Systematic Literature Review.

作者信息

El-Saifi Najwan, Moyle Wendy, Jones Cindy, Tuffaha Haitham

机构信息

1 School of Nursing and Midwifery, Menzies Health Institute Queensland, Griffith University, Nathan Campus, Brisbane, Queensland, Australia.

2 School of Medicine, Menzies Health Institute Queensland, Griffith University, Nathan Campus, Brisbane, Queensland, Australia.

出版信息

J Pharm Pract. 2018 Jun;31(3):322-334. doi: 10.1177/0897190017710524. Epub 2017 May 24.

DOI:10.1177/0897190017710524
PMID:28539102
Abstract

BACKGROUND

Older patients with dementia are often unable to take their medications as prescribed due to cognitive and physical impairment.

OBJECTIVES

To review the evidence on medication adherence in older patients with dementia in terms of the level of adherence, outcomes, contributing factors, and available interventions.

METHODS

A systematic literature review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searched databases included CINAHL, Cochrane Library, DARE, MEDLINE, and PubMed.

RESULTS

Eighteen studies reported levels of medication adherence or discontinuation and related factors. Medication adherence ranged from 17% to 42%, and medication discontinuation before the end of treatment ranged from 37% to 80%. Nonadherence was associated with an increased risk of hospitalization or death, while increasing age, choice of medication, use of concomitant medications, and medicines' costs were reported to decrease medication adherence. Telehealth home monitoring and treatment modification were the only interventions reported in the literature to improve medication adherence in this population.

CONCLUSION

Older patients with dementia have a low level of medication adherence. Future research should focus on the development and implementation of interventions to help older patients with dementia and their caregivers make better use of medications.

摘要

背景

患有痴呆症的老年患者常因认知和身体功能障碍而无法按医嘱服药。

目的

从依从性水平、结局、影响因素和可用干预措施等方面综述老年痴呆患者药物依从性的相关证据。

方法

按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行系统文献综述。检索的数据库包括护理学与健康领域数据库(CINAHL)、考克兰图书馆、循证卫生保健数据库(DARE)、医学索引数据库(MEDLINE)和医学期刊数据库(PubMed)。

结果

18项研究报告了药物依从性或停药水平及相关因素。药物依从性范围为17%至42%,治疗结束前停药率范围为37%至80%。不依从与住院或死亡风险增加相关,而年龄增长、药物选择、合并用药的使用以及药物费用据报道会降低药物依从性。远程医疗家庭监测和治疗调整是文献中报道的仅有的可改善该人群药物依从性的干预措施。

结论

老年痴呆患者的药物依从性较低。未来研究应聚焦于开发和实施干预措施,以帮助老年痴呆患者及其照护者更好地用药。

相似文献

1
Medication Adherence in Older Patients With Dementia: A Systematic Literature Review.老年痴呆患者的药物依从性:一项系统文献综述
J Pharm Pract. 2018 Jun;31(3):322-334. doi: 10.1177/0897190017710524. Epub 2017 May 24.
2
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
3
Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication.为正在服用长期药物的慢性病患者的用药依从性向医生提供反馈。
Cochrane Database Syst Rev. 2018 Jan 10;1(1):CD012042. doi: 10.1002/14651858.CD012042.pub2.
4
Multifaceted behavioral interventions to improve topical glaucoma therapy adherence in adults.多方面行为干预以提高成人局部青光眼治疗的依从性。
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD015788. doi: 10.1002/14651858.CD015788.pub2.
5
Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care.为长期护理中的痴呆症患者改善心理社会状况而量身定制的活动。
Cochrane Database Syst Rev. 2018 Feb 13;2(2):CD009812. doi: 10.1002/14651858.CD009812.pub2.
6
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
7
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
8
Cholinesterase inhibitors for Parkinson's disease dementia.用于帕金森病痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004747. doi: 10.1002/14651858.CD004747.pub2.
9
Digital interventions to improve adherence to maintenance medication in asthma.数字干预措施以提高哮喘维持药物治疗的依从性。
Cochrane Database Syst Rev. 2022 Jun 13;6(6):CD013030. doi: 10.1002/14651858.CD013030.pub2.
10
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.改善镰状细胞病或地中海贫血患者铁螯合疗法依从性的干预措施。
Cochrane Database Syst Rev. 2018 May 8;5(5):CD012349. doi: 10.1002/14651858.CD012349.pub2.

引用本文的文献

1
Top 10 consumer and healthcare professional priorities for research in the field of quality use of medicines in people living with dementia.痴呆症患者用药质量领域研究的十大消费者及医疗保健专业人员优先事项。
J Alzheimers Dis. 2025 Jul 27;107(1):13872877251359984. doi: 10.1177/13872877251359984.
2
Clinical and economic consequences of medication nonadherence: a review of systematic reviews.药物治疗不依从的临床和经济后果:系统评价的综述
Front Pharmacol. 2025 Jun 25;16:1570359. doi: 10.3389/fphar.2025.1570359. eCollection 2025.
3
Healthcare related costs associated with donepezil use in patients with very mild dementia due to Alzheimer's disease: A retrospective observational study.
与使用多奈哌齐治疗阿尔茨海默病所致极轻度痴呆患者相关的医疗保健费用:一项回顾性观察研究。
J Alzheimers Dis Rep. 2025 Jul 1;9:25424823251356233. doi: 10.1177/25424823251356233. eCollection 2025 Jan-Dec.
4
Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.识别痴呆症护理中的风险:来自与临床药剂师的定性研究的见解。
PLoS One. 2025 Jun 24;20(6):e0325472. doi: 10.1371/journal.pone.0325472. eCollection 2025.
5
Persistence with anti-dementia medications: a systematic review and meta-analysis.抗痴呆药物的持续使用:一项系统评价与荟萃分析
Age Ageing. 2025 May 31;54(6). doi: 10.1093/ageing/afaf151.
6
Bioequivalence of a Donepezil/Memantine 10/20 mg Fixed-Dose Combination Versus Single-Component Tablets in Healthy Korean Males.多奈哌齐/美金刚10/20毫克固定剂量复方制剂与单组分片剂在健康韩国男性中的生物等效性
Clin Pharmacol Drug Dev. 2025 Sep;14(9):710-716. doi: 10.1002/cpdd.1556. Epub 2025 May 30.
7
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.《降低通胀法案》下患有痴呆症的医疗保险受益人的自付药品费用变化:一项模拟研究
Value Health. 2025 Apr;28(4):553-561. doi: 10.1016/j.jval.2025.01.008. Epub 2025 Jan 27.
8
Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records.韩国视障人士与非残疾人士在血脂异常药物治疗依从性方面无显著差异:一项使用理赔记录的全国性队列研究。
PLoS One. 2025 Jan 8;20(1):e0307764. doi: 10.1371/journal.pone.0307764. eCollection 2025.
9
The indirect effect of nonadherence on health-related quality of life in older adults with neurological disorders: implications for clinical endpoints and interventions.不依从性对患有神经系统疾病的老年人健康相关生活质量的间接影响:对临床终点和干预措施的启示。
Front Neurol. 2024 Nov 25;15:1462478. doi: 10.3389/fneur.2024.1462478. eCollection 2024.
10
Anti-Amyloid Drugs for Alzheimer's Disease: Considering the Role of Depression.用于治疗阿尔茨海默病的抗淀粉样蛋白药物:考虑抑郁症的作用。
Neurodegener Dis. 2025;25(1):36-49. doi: 10.1159/000541783. Epub 2024 Dec 6.